CEL-SCI

+$1.72 (+8.35%) Today
-$0.33 (-1.48%) As of 11:59 PM UTC after-hours

Why Robinhood?

You can buy or sell CEL-SCI and other stocks, options, and ETFs commission-free!

About CVM

Cel-Sci Corporation, also called CEL-SCI, is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).

CEO
Geert R. Kersten
Employees
—
Headquarters
Vienna, Virginia
Founded
1983

CVM Key Statistics

Market Cap
941.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
597.44K
High Today
$22.71
Low Today
$20.31
Open Price
$21.00
Volume
562.01K
52 Week High
$40.91
52 Week Low
$10.76

CVM Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 28, Pre-Market

You May Also Like

RHE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure